The 4 analysts offering 1 year price forecasts for IRD have a max estimate of — and a min estimate of —.
Analyst rating
Based on 4 analysts giving stock ratings to IRD in the past 3 months.
EPS
Reported
Estimate
Reported
Estimate
Surprise
Revenue
Reported
Estimate
Reported
Estimate
Surprise
Be warned
This info isn't a recommendation for what you should personally do, so please don't take the data as investment advice. As with any trade, always look first, then leap. Read more in the Terms of Use.
Frequently Asked Questions
IRD EPS for the last quarter is −0.29 USD despite the estimation of −0.24 USD. In the next quarter EPS is expected to reach −0.06 USD. Track more of Opus Genetics, Inc. financials and stay on top of what is up with the company.
In the next quarter Opus Genetics, Inc. revenue is expected to reach 8.83 M USD. Check out Opus Genetics, Inc. revenue and earnings and make informed decisions.
According to analysts, IRD price target is 10.50 USD with a max estimate of 15.00 USD and a min estimate of 8.00 USD. Check if this forecast comes true in a year, meanwhile watch Opus Genetics, Inc. stock price chart and keep track of the current situation with IRD news and stock market news.